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Thomas K. Chung, MS, and Richard P. Cambria, MD, Boston, Mass
Objective:Hybrid repair of thoracoabdominal aortic aneurysms (TAAA) may reduce morbidity and mortality in high-risk
candidates for open repair. This study reviews the outcomes of hybrid TAAA repair for Crawford extent I-III TAAA in
high-risk patients in comparison to patients who underwent concurrent open TAAA repair.
Methods: During the interval from June 2005 to December 2007, a total of 23 high-risk patients with TAAA (type I: 9
[39%], II: 5 [22%], and III: 9 [39%]) underwent renal and/or mesenteric debranching (11 [48%] with four vessel
debranching) with subsequent placement of a thoracic stent graft; 77 patients underwent open TAAA repair (type I: 13
[17%], II: 11 [14%], III: 27 [35%], and IV: 26 [34%]) during the same interval. The primary high-risk criteria for hybrid
TAAA included advanced age/poor functional status (n  14), major pulmonary dysfunction (n  8), and technical
consideration (prior thoracic aortic aneurysm repair [n  4] or prior thoracoabdominal aneurysm repair [n  2] and
obesity [n  2]) with 6 patients having overlapping high-risk criteria. Composite (30-day) mortality and/or permanent
paraplegia (PP) were the major study endpoints.
Results: The hybrid and open TAAA groups had (respectively) no statistical difference in mean age (76.6 vs 72.7 years),
aneurysm size (6.51 vs 6.52 cm), and non-elective operation (30.4% vs 26.0%). The hybrid group had a higher mean
Society for Vascular Surgery (SVS) risk score (9.1 vs 6.0; P < .001), incidence of oxygen-dependent chronic obstructive
pulmonary disease (COPD) (34.8% vs 2.6%; P < .001), and prior thoracic (n  4) or thoracoabdominal (n  2) repair
(26.1% vs 1.3%; P< .001). Composite mortality and/or PP was doubled in the hybrid group (21.7% vs 11.7%; P .33).
The rate of any type of reoperation was higher in hybrid TAAA repair (39.1% vs 20.8%; P  .03). One year actuarial
survival for both groups was comparable (hybrid, 68  12%; open, 73  6%). A total of 5/23 (22%) hybrid TAAA
patients developed an endoleak (type I: 3/23 and type II: 2/23) with 3 requiring endovascular re-intervention. A total
of 7/70 (10%) visceral/renal bypass grafts were noted to be occluded during follow-up (1 superior mesenteric artery, 1
celiac, and 5 renal). Examination of patients with an SVS risk score <8 (mean SVS risk score in hybrid 6.2 [n  10] vs
5.5 [n 68] in open; P .27) revealed the hybrid group had a higher incidence of composite mortality and/or PP (40%
vs 10.3%; P  .03).
Conclusion: Hybrid TAAA repair in high-risk patients has significant morbidity and mortality suggesting a non-
interventional approach may be appropriate in many such patients. The morbidity and mortality of the hybrid TAAA
repair was substantial even in lower risk patients (SVS risk score <8), albeit patient numbers were small. Prospective
study in comparable patient risk cohorts is required to define the role of hybrid TAAA repair. ( J Vasc Surg 2009;50:
15-22.)Prior to the commercial availability of thoracic stent
grafts, formal open operation was the only technical solu-
tion for the treatment of thoracoabdominal aortic aneu-
rysm (TAAA). While favorable results have been achieved
in high volume centers,1-3 the “real world” mortality of this
operation across a spectrum of hospitals exceeds 20%.4
Rigberg et al5 noted an overall mortality of 19% at 1 year in
the state of California with a linear, even dramatic correla-
tion with patient age such that patients greater than 75
years of age had an aggregate 1 year mortality of 40% after
TAAA repair. In our experience, perioperative mortality
across a spectrum of patient clinical presentations has
been a consistent 8% over the past 20 years.3,6 Additional
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doi:10.1016/j.jvs.2008.12.051follow-up studies have documented both favorable durabil-
ity of such repair7 and preserved functional status in long-
term surviving patients.8 However, patients unfit to with-
stand open operation are commonly encountered and their
prognosis is poor.9 Often significant chronic obstructive
pulmonary disease (COPD) precludes open TAAA repair,
with the clinical conundrum that such pulmonary disease
constitutes an independent and well validated risk factor for
aneurysm expansion and rupture.10,11
There is consensus that endovascular aneurysm re-
pair (EVAR) is the preferred treatment for high-risk
patients with abdominal aortic aneurysms.12,13 While
totally endovascular-branched graft repair has been re-
ported for high-risk TAAA patients,14,15 the availability of
such constructs in the United States is quite limited. Fur-
thermore, given the significant logistical and regulatory
technical issues with custom made branched grafts and the
wide variability of visceral segment anatomy in TAAA pa-
tients, this situation is unlikely to change in the near future.
Hybrid operations which combine both open (typically
visceral/renal debranching) and endovascular techniques
were first reported in 1999.16 This consists of an open
15
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aorta is debranched via extra-anatomic bypass grafts origi-
nating from the distal abdominal aorta or iliac arteries to
provide a distal seal zone for subsequent placement of a
thoracic endograft. The endograft distal attachment site
can be either in the native visceral segment, an infrarenal
graft or even the iliac arteries.17
The hybrid repair of TAAA has been suggested to have
lower mortality in high-risk patients18,19 and is the pre-
ferred repair at certain centers20 largely with the rationale
that open operation has produced unacceptable morbidity.
Other reports of hybrid TAAA repair involving visceral
vessels have demonstrated no significant difference in out-
comes to open TAAA repair.21 Accordingly, the hybrid
operation has been applied in heterogeneous patient
groups in single center studies and no prospective compar-
ative study of this strategy exists. In the present study, we
report our experience with hybrid operations in patients
unfit for open operation; for perspective and comparison,
concurrently treated patients undergoing open TAAA are
included.
METHODS
This retrospective study of prospectively gathered clin-
ical data was approved by the Massachusetts General Hos-
pital Institutional Review Board. A total of 23 high-risk
patients with thoracoabdominal aneurysms underwent ei-
ther mesenteric or mesenteric and renal debranching with
subsequent thoracic endograft placement between June
2005 and December 2007. These patients were compared
with patients who underwent an open TAAA repair (n 
77) during the same time period.
Patients in the hybrid group were stratified as high risk for
open repair based on advanced age/poor functional status
(mean age 81 years, n  14), severe oxygen-dependent
COPD (n 8), obesity (n 2), or previous open thoracic
(n  4) or TAAA repair (n  2) with 6 patients having
overlapping high-risk criteria. The median age for this
group was 76.6 years with a range of 59 to 86 years. The
mean aneurysm size was 6.5 cm (range, 5.2 to 8.5 cm). A
total of 69.6% of the hybrid patients presented on an
elective basis and TAAA extent by Crawford classification
was; type I: 9 (39%), type II: 5 (22)%, type III: 9 (39%), and
type IV: 0 (0%). Hybrid TAAA repair was not considered
for patients with extent IV TAAA as the perceived surgical
insult for debranching equates that of formal open repair of
such lesions. The majority (n  13) of patients underwent
staged repair with a mean interval between stages of 3 days
excluding 1 patient who had a delayed interval of 82 days
partly due to a myocardial infarction after the first surgery.
Ten patients underwent a single-staged procedure.
Staged patients underwent debranching of the renal
and/or mesenteric vessels first followed by placement of a
thoracic endograft (W.L. Gore & Assoc, Flagstaff, Ariz)
including coverage of the visceral vessel origins. Single-
staged procedures involved the mesenteric debranching
followed by the placement of the thoracic endograft. Since
long segment thoracic aortic coverage was routine, place-ment of a cerebrospinal fluid drainage catheter was used in
all hybrid cases. Mesenteric debranching was performed via
a midline laparotomy with multi-branched Dacron grafts
sutured to the native infrarenal aorta (n  5), infrarenal
graft placed during debranching (n  7), previous infrare-
nal graft (n 8), or native iliac arteries (n 3). Debranch-
ing involved all four mesenteric/renal vessels (n  11),
mesenteric alone (n  8), or a variation thereof (n  4).
Placement of the thoracic endograft was via the femoral
arteries or conduit if the iliac artery diameter would not
accommodate the device. Postoperatively, all patients were
placed in the intensive care unit. The cerebrospinal catheter
was removed 48-72 hours thereafter. Patient follow-up was
at 1 month, between 3 to 6 months, and at 1 year. The
Social Security Death Index, hospital computerized
records, or telephone follow-up were used to verify patient
deaths. Preoperative Society for Vascular Surgery (SVS) risk
scores were calculated in a manner previously reported.22
The open TAAA group consisted of 77 consecutive
patients (Crawford extent type I: 13 [17%], type II: 11
[14%], type III: 27 [35%], and type IV: 26 [34%]) who
underwent open TAAA repair during the same time period
as the hybrid patients’ treatment. The mean age for the
patient population was 72.7 years (range, 38-92 years) and
the mean aneurysm size was 6.5 cm (range, 4-10 cm). A
total of 74.0% underwent elective repair. Preoperative SVS
scores were calculated in a similar manner as in the hybrid
group. During surgery, routine use of cerebrospinal cathe-
ter drainage was employed in extent I-III TAAA. Details of
the technical aspects of surgery have been previously re-
ported.6 Patients were evaluated at 1 month and at 1 year.
The two groups were compared using 2 and Fisher’s
exact t test where appropriate. Primary endpoints of this
study were mortality, permanent neurological deficit, and
composite mortality and/or permanent neurological defi-
cit. Secondary endpoints included intermediate term actu-
arial survival, myocardial infarction, and any surgical re-
intervention at any time. Time-based endpoints were
Table I. Demographic and clinical features
Hybrid repair
n  23
Open repair
n  77 P value
Age (years) 76.6  7.1 72.7  10.1 .085
Male 7 (30.4%) 36 (46.8%) .165
Diabetes mellitus 6 (26.1%) 8 (10.4%) .057
Severe COPD (oxygen
dependant) 8 (34.8%) 2 (2.6%) .0001
Hypertension (severe: 3
or  meds) 11 (47.8%) 18 (23.4%) .023
Tobacco (past or
current) 16 (69.6%) 29 (37.7%) .007
Compensated CHF or
arrhythmia 10 (43.5%) 15 (19.5%) .020
Creatinine, serum
(1.5 mg/dL) 5 (23.8%) 27 (35.1%) .434
SVS risk score 9.13  3.17 6.01  2.25 .0001
COPD, Chronic obstructive pulmonary disease; CHF, congestive heart
failure; SVS-ISCVS risk score.22analyzed using Kaplan-Meier life table analysis.
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Demographics and clinical features of the study
groups are displayed in Table I. Cardiopulmonary co-
morbidities and composite SVS risk score were signifi-
cantly elevated in the hybrid group. There was no signif-
icant difference in aneurysm size and nonelective
operation between groups; however the hybrid group
was noted to have a higher proportion of patients with
reoperative thoracic or descending TAAA repairs as de-
tailed in Table II.
The hybrid group had a greater than twofold increase in
Table II. Preoperative anatomy and clinical presentation
Hybrid repair
n  23
Open repair
n  77 P value
TAAA extent
I 9 (39%) 13 (17%)
II 5 (22%) 11 (14%)
III 9 (39%) 27 (35%)
IV 0 (0%) 26 (34%)
Mean aneurysm size (cm) 6.51  0.7 6.52  1.04 .947
All prior aortic operations
AAA 6 (26.1%) 20 (26.0%) .991
Asc/arch 2 (8.7%) 4 (5.2%) .619
TAA/TAAA 6 (26.1%) 1 (1.3%) .001
Clinical presentation
Elective 16 (69.6%) 57 (74.0%) .912
Urgent nonruptured 5 (21.7%) 14 (18.2%)
Ruptured 2 (8.7%) 6 (7.8%)
AAA, Abdominal aortic aneurysm; Asc/arch, ascending or aortic arch aneu-
rysm; TAA, thoracic aortic aneurysm; TAAA, thoracoabdominal aortic
aneurysm.
Table III. Complications and disposition
Hybrid repair
n  23
Open repair
n  77 P value
Perioperative death (30
day) 4 (17.4%) 6 (7.8%) .232
In-hospital Death 6 (26.1%) 8 (10.4%) .271
Paraplegia (permanent) 1 (4.3%) 3 (3.9%) .983
Composite death and
paraplegia (30 day) 5 (21.7%) 9 (11.7%) .334
Cardiac
Myocardial infarction 5 (21.7%) 7 (9.1%) .14
Arrhythmia 3 (13.0%) 8 (10.4%) .712
Stroke 0 (0%) 1 (1.3%) 1
Pulmonary
Pneumonia 4 (17.4%) 14 (18.2%) 1
Tracheostomy 1 (4.3%) 11 (14.3%) .286
Any reoperation 9 (39.1%) 16 (20.8%) .033
Length of stay (days) 14.9 (3-69) 18.3 (0-98) .369
Disposition upon discharge
Home 3 (13.0%) 14 (18.2%)
Rehabilitation/skilled
nursing home 14 (60.9%) 54 (70.1%)
Perioperative death was defined as any death  30 days; In-hospital death
was defined as any death which occurred during same hospitalization as the
hybrid or open thoracoabdominal aneurysm operation; composite death and
paraplegia were defined as either death and/or permanent paraplegia  30
days.perioperative death but, as detailed in Table III, this did notachieve statistical significance. There were six ruptures in
the open group with two deaths representing 25% of the
in-hospital deaths and two ruptures in hybrid group with
one death representing 17% of the in-hospital deaths; with
such small numbers data analysis was not performed specif-
ically examining mortality in rupture vs elective patients in
the hybrid and open groups. Excluding type IV TAAA from
the open group as the hybrid group did not have any type
IV TAAA, did not significantly alter in-hospital mortality
(hybrid, 26% vs open, 13%; P  .17). The Kaplan-Meier
curve demonstrated no difference in survival at 1 year
between the two groups (Fig) albeit this analysis is ham-
pered by small numbers available for such follow-up at 1
year. Both groups had similar rates of paraplegia. Interest-
ingly, the hybrid group had a significantly higher rate of any
surgical re-intervention (34.8% vs 20.8%; P  .03) such as
required for tracheostomy, bleeding, wound disruption,
endoleak, graft thrombosis, etc. Postoperative complica-
tion rates for renal failure, arrhythmia, and pneumonia were
not different. There was a trend towards a high rate of
myocardial infarction in the hybrid group (21.7% vs 9.1%;
Fig. Open: Mean follow-up 179 days (median 100) (range, 1 to
710). Hybrid: Mean follow-up 166 days (median 68) (range, 2 to
580).
Interval
start time
Number
entering
interval
Number
withdrawing
during
interval
Cumulative
proportion
surviving at end
of interval  SE
Hybrid 0-1 year 23 5 0.68  0.12
1-2 years 3 1 0.34  0.25
Open 0-1 year 77 14 0.73  0.06
1-2 years 14 0 0.73  0.06P  .14), however, this was not statistically significant. Of
g graf
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thrombosis rate (7/70 bypass grafts) with 1 patient having
3/4 grafts thrombosed due to heparin-induced thrombocy-
Table IV. Demographic and follow-up data for 23 patien
Name Age
Svs Risk
Score
Crawford
Extent
Prior
Surgery
Clinical
Presentation
RS 83 12 3 Elective S
AG 77 11 3 AAA Urgent C
WD 64 8 2 TAA Urgent
(enteric
fistula)
C
FO 80 14 1 TAAA Urgent C
SM 85 11 3 AAA Elective C
GG 80 4 3 TAA Elective S
MG 75 14 2 AA Elective C
JC 76 8 2 Elective S
SL 60 10 1 Elective S
FB 80 2 1 Elective S
MP 86 7 1 AAA Elective S
BR 83 6 2 Urgent S
DO 75 9 1 Elective S
JM 81 12 1 AAA, TAAA Rupture C
RL 76 14 3 TAA, AAA Rupture C
CM 82 11 3 AAA Elective C
AF 82 9 3 Urgent S
TF 72 10 1 Elective S
CS 79 7 3 Elective C
ER 73 6 1 TAA Elective S
HT 77 7 3 Elective C
RL 63 11 1 AAA Elective S
LB 60 7 1 Elective S
AA, Aortic arch aneurysm; AAA, abdominal aortic aneurysm; ARDS, acute re
infarction; RRA, right renal artery; SMA, superior mesenteric artery; SP,
aneurysm.
Indications for any surgical reoperation are depicted. Complication detailin
marked with death in parenthesis.topenia and 5/23 patients (22%) developing an endoleak with3 patients requiring a total of four endovascular re-interven-
tions. The details describing preoperative and operative vari-
ables in addition to complications and deaths in the hybrid
o underwent TAAA hybrid procedure
ges
Visceral
Bypasses
Reoperation
Indications Complications
LRA, RRA, C,
SMA
Dehiscence
rrent LRA, RRA, SP,
SMA
Femoral artery
bleeding
MI
rrent C, SMA Explant due to
exposed
endograft in
esoph,
tracheostomy
Pneumonia, sepsis
(death)
rrent C, SMA Type 2 endoleak
rrent LRA, SMA
LRA, RRA, C,
SMA
MI, graft
thrombosis
(RRA)
rrent LRA, RRA, C,
SMA
graft thrombosis
(LRA and RRA),
on Hemodialysis
LRA, RRA, C,
SMA
Paraplegia (resolved
with spinal
drainage)
LRA, RRA, C,
SMA
Type 2 endoleak
LRA, RRA, C,
SMA
Craniotomy for
subdural
hemorrhage
Permanent
paraplegia, MI
LRA, RRA, C,
SMA
Pneumonia, ARDS
(death), MI, graft
thrombosis
(LRA), Renal
Failure
LRA, RRA, C,
SMA
Cardiac arrest
(death)
C, SMA Type 1 endoleak
repair
Type 1 endoleak
rrent RRA, C, SMA Common bile
duct injury
Pneumonia, Liver
failure (death)
rrent SMA Sepsis, Pneumonia
rrent C, SMA Type 1 endoleak
repair
Type 1 endoleak
RRA, C, SMA
C, SMA Type 1 endoleak
repair  2
Type 1 endoleak
rrent LRA, RRA, C,
SMA
Rupture of TAAA
between staged
procedure
(death)
LRA, RRA, C
rrent LRA, RRA, C,
SMA
Graft
thrombectomy
Graft thrombosis
(C, SMA, and
RRA) (death)
C, SMA MI
C, SMA
ry distress syndrome; C, celiac artery; LRA, left renal artery; MI, myocardial
c artery; TAA, thoracic aortic aneurysm; TAAA, thoracoabdominal aortic
t thrombosis and type and any complication attributed to death are clearlyts wh
Sta
taged
oncu
oncu
oncu
oncu
taged
oncu
taged
taged
taged
taged
taged
taged
oncu
oncu
oncu
taged
taged
oncu
taged
oncu
taged
taged
spirato
splenigroup are detailed in Table IV.
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risk scores between the two groups was used in an at-
tempt to compare periprocedural results among similar
risk profile patients. As with the main group, there
was no difference in the major categories in patient
demographics (Table V) in both subgroups of hybrid
(n  10) and open (n  68) patients. Composite 30-day
mortality and/or permanent paraplegia rates was noted
to be higher in the hybrid group (40% vs 10.3%; P 
.03), although small patient numbers hamper such
analysis.
DISCUSSION
From a practical standpoint, the hybrid operation has
been available to most surgeons since commercial approval
of the first thoracic endograft in April 2005.23 It is ac-
knowledged that this technique will serve as a stopgap
measure until widespread availability of branched thoraco-
abdominal endografts wherein impressive early results in
high-risk patients has recently been reported in patients
considered unfit candidates for open repair.15 Albeit the
comparison is on the basis of small numbers, a periproce-
Table V. Demographics, preoperative anatomy and
complications in patients with SVS 8
Hybrid repair
N  10
Open repair
N  68 P value
Age 76.2  8.3 72.5  10.6 .299
Gender (male) 2 (20%) 30 (44.1%) .184
Diabetes mellitus 2 (20.0%) 5 (7.4%) .219
Severe COPD 1 (10.0%) 0 (0%) .031
Hypertension (severe: 3
or  meds) 4 (40.0%) 13 (19.1%) .212
Hypercholesterolemia 3 (30.0%) 38 (55.9%) .178
Tobacco (past or current) 4 (40.0%) 24 (35.3%) .740
Compensated CHF or
arrhythmia 3 (30.0%) 11 (16.2%) .373
Serum Creatinine (1.5
mg/dL) 2 (20.0%) 22 (32.4%) .715
SVS risk score 6.20  1.87 5.51  1.83 .274
TAA extent
I 5 (50%) 12 (17.6%)
II 2 (20%) 9 (13.2%)
III 3 (30%) 23 (33.8%)
IV 0 22 (32.3%)
Mean aneurysm size (cm) 6.43  0.73 6.47  1.02 .918
All prior aortic operations
AAA 1 (10.0%) 19 (27.9%) .438
Asc/arch 1 (10.0%) 3 (4.4%) .429
TAA/TAAA 3 (30.0%) 1 (1.5%) .006
Clinical presentation
Elective 8 (80.0%) 50 (73.5%)
Urgent nonruptured 2 (20.0%) 6 (8.8%)
Ruptured 0 6 (8.8%)
Postoperative MI 3 (30.0%) 5 (7.4%) .061
Perioperative death 3 (30.0%) 5 (7.4%) .061
Paraplegia 1 (10.0%) 3 (4.4%) .553
Composite death and
paraplegia 4 (40.0%) 7 (10.3%) .03
Length of stay (days) 17.1  20 18.6  16.7 .795dural mortality of 9.1% as noted by Chuter et al15 comparesfavorably with the results detailed herein. Considering reg-
ulatory and logistical constraints in the current generation
of branched endografts viz, the significant time delay in
their fabrication, widespread availability is hardly immi-
nent. Thus, the hybrid operation will likely remain in the
armamentarium of the vascular surgeon for the foreseeable
future, at least in application for urgent cases wherein delays
in treatment for custom stent graft fabrication are not
possible.
Given the significant morbidity and mortality of open
TAAA, especially beyond high volume centers,4 limiting
the scope of the operation, especially for patients with
major comorbidities, seems intuitively logical. Hybrid re-
pair by the avoidance of the thoracotomy, potential paral-
ysis of the left hemi-diaphragm, and cross-clamping of the
aorta, at least in theory, has the potential to decrease overall
morbidity. The potential benefit of reduced spinal cord
ischemia has also been suggested,20 but in fact not realized
in the available literature. Our focus was to review results in
patients denied open repair similar to the original EVAR
paradigm.13,24 A significant proportion of the hybrid pa-
tients (n  18; 78%) were followed for a period of time as
they were not candidates for open operation given their
comorbidities. Perhaps most notable in this regard were
patients with severe COPD. The patient with severe COPD
and TAAA constitutes a common judgmental paradox as
they are both at increased risk of pulmonary complications
after operation and aneurysm expansion and rupture prior
to surgery.9-11 In Crawford’s series of 94 patients denied
open operation for TAAA, 46% of such judgments were
related to COPD;9 8 (35%) of our patients underwent
hybrid repair related to severe COPD. It seemed intuitively
logical that avoidance of a thoracotomy and disturbance of
the left hemidiaphram function would translate into de-
creased pulmonary morbidity, the single most frequent
occurring complication of open TAAA repair.3 Hybrid
operation may also have an advantage in the setting of redo
thoracotomy, wherein bleeding and left lung contusion are
potentially problematic.25
The hybrid repair has been suggested to have lower
spinal cord ischemia with paraplegia rates reported from
0%20 to as high as 16%19 (Table VI). This rationale is
based on the avoidance of aortic cross-clamping and also
as an extension of the experience with thoracic endovas-
cular aneurysm repair (TEVAR) for repair of isolated
thoracic aneurysms.26,27 Several comparative trials have
documented decreased risk of spinal cord ischemia com-
plications with TEVAR vs open repair of thoracic aortic aneu-
rysms.27,28 However, similar to results in this study, our
experience with TEVAR for isolated descending aneurysm
dispute this purported advantage for TEVAR.29 Presumably
this is referable to our favorable results with low rates of spinal
cord ischemia as reported herein and previously.3,6,29 The
comparison between TEVAR for descending aortic aneu-
rysms and hybrid repair of TAAA is not valid as hybrid
operations involve long segment thoracoabdominal cover-
age which has been shown to increase spinal cord ischemic
complication;30 hybrid operations may also involve replace-
electiv
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thoracoabdominal stent graft placement, again increasing
the risk for spinal cord ischemia. While touted as a surgery
of limited extent, hybrid repair of TAAA is yet an operation
of significant magnitude; given the small numbers of pa-
tients studied in recent reports, no firm conclusions can be
made regarding the benefit of hybrid operations with re-
spect to spinal cord ischemia. In fact, the low paraplegia
rates reported by Black et al20 are specious. These investi-
gators having updated their series, now report paraplegia
rates of 15-20%.31
Patient selection for hybrid operations has been varied
in the literature. The majority of studies, as with ours, have
described the hybrid operation in patients unfit for tradi-
tional open repair.18,19,21 In fact, 18/23 (78%) of our
hybrid group had been followed with TAAA prior to the
study interval and offered hybrid repair once this became
feasible from a regulatory perspective. Our own results and
those of Chiesa et al21 demonstrated significant mortality in
high-risk patients. At least one center invoking unaccept-
able risks of open TAAA repair have applied hybrid opera-
tion for all TAAAs.20 Including the ruptured patients, their
overall 30-day mortality was 23%. Also, our study did not
include any type IV TAAAs for the hybrid operation. In this
particular patient group, the extent of the incision, context,
and duration of the operation demonstrate no definitive
advantage with traditional open repair. While our data did
compare hybrid patients with all patients undergoing open
TAAA repair, exclusion of type IV TAAA from the open
group did not change overall results. While there is consen-
sus that TAAA extent greatly influences the risk of spinal
cord ischemic complications, our prior experience indi-
cated no relation between TAAA extent and perioperative
mortality.3,6
The capacity for endoleaks (Table VI) is a disadvantage
of hybrid repair and the relatively high incidence accompa-
nying hybrid TAAA repair presumably relates to compro-
mised fixation sites. Perhaps this could be improved by
routinely performing four vessel debranching, but our ex-
perience indicates this strategy is to be avoided unless
anatomically mandated. Endoleak rates as high as 42%20
have been reported (Table VI). A significant proportion of
the endoleaks involved (type I) proximal and distal attach-
Table VI. Summary of results from previous hybrid TAAA
Author Patients (n)
% unfit for open
repair Extent I/I
Black19 26a (completed
procedure)
unknown 10%/62%
Chiesa20 13 100% 54%/15%
Zhou17c 31 (15 visceral) 100% 17%/0%
Brockler18 28 100% 9%/29%
Current series 23 100% 36%/23%
aThis series reported 29 patients in which hybrid was attempted with 26 p
aborted; bOverall mortality included the six rupture patients who died, for
hybrid arch debranching in addition to hybrid mesenteric debranching.ment sites which required reintervention. In one series,204/6 patients with type I leaks underwent reintervention
with 3 patients still having an endoleak. Three of our
patients required reintervention for type I endoleaks with
one reintervention failure.
Another concern identified in the hybrid TAAA repair was
the unexpectedly high rate (10%) of renal/visceral graft
thrombosis. Exclusion of 1 patient with heparin-induced
thrombocytopenia (HIT) syndrome and thrombosis of three
out of four grafts would modulate our rate of graft thrombosis
to 6%, similar to previously published reports.18 Also, exclu-
sive of the patient with heparin-induced thrombocytope-
nia, all of the thrombosed grafts were to the renal arteries.
Given our prior reports of the reliability/durability of sur-
gical renal artery reconstruction,32 a failure rate of 19%
(5/27) was surprising, especially when our previously re-
ported renovisceral thrombosis rate in patients undergoing
open TAAA repair was 1.6%.7 Likely, the technical nuances
of reconstruction of (in particular) the right renal artery
around a significant aneurysm and problems with a redo
surgical field, contributed to the significant problem with
graft thromboses. Technical options for creation of the
debranching bypasses are many and have been reviewed
elsewhere.33
Technical considerations of the hybrid operation also
include the consideration of a simultaneous approach or
a two-stage procedure.19,33 This reflects an operation in
evolution. Proponents of the simultaneous approach
argue minimal access site-related complications as a con-
duit directly on the aorta or iliac artery can be utilized
and direct surgical adjuncts can facilitate identification of
the distal landing zone. Disadvantages include longer
duration of operation, logistical constraints with imag-
ing equipment, and an increased risk of renal failure
given the ischemic time coupled with contrast adminis-
tration.
Proponents of the two-staged approach argue im-
proved recovery and avoidance of simultaneous abdominal
and thoracic grafting which has been correlated in some
reports with increased risk of spinal cord ischemia.34 Dis-
advantage of the two-stage approach includes the possibil-
ity of interval rupture which, in fact, occurred in our very
first patient and in the experience of others.19
Limitations of the current study, similar to the ma-
ers
Mortality
(30 day) Paraplegia Endoleak
Debranching
graft patency
3%b (overall) 0% 42% 98%
23% 8% n  1 (delayed) 0% 100%
3% (n  1) 0% 6% 95%
14% 16% 18% 89% (30 day)
17% 4% 22% 90%
s successfully completing the hybrid and 3 patients having the procedure
e/urgent repair 30-day mortality was reported as 13%; cthis series includedpap
I
2
atientjority of previously published reports of hybrid repair of
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Volume 50, Number 1 Patel et al 21TAAA, are its retrospective nature and the heterogeneity
of the study groups with respect to risk factor profile.
Inclusion of the open group is perhaps more for perspec-
tive rather than comparison. The small numbers of pa-
tients in this study, especially when comparing patients
with SVS risk score of 8, was also a limiting factor. The
analogy with extending EVAR and TEVAR to high-risk
patients may not extend to hybrid repair of TAAAs. With
a sobering 26% in-hospital mortality, it is clear that a
conservative application of this strategy in patients unfit
for conventional operation is appropriate. We currently
reserve it for large TAAAs in patients with normal renal
function. Prospective study of hybrid TAAA repair to
open operation in similar risk patients will be required to
define its role.
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